Antiepileptic drugs and bone metabolism
2006

Antiepileptic Drugs and Bone Metabolism

Sample size: 624 publication Evidence: moderate

Author Information

Author(s): Valsamis Helen A, Arora Surender K, Labban Barbara, McFarlane Samy I

Primary Institution: SUNY Downstate Medical Center

Hypothesis

The use of antiepileptic drugs (AEDs) is associated with adverse effects on bone health, including low bone mass and increased fracture risk.

Conclusion

Antiepileptic drugs significantly increase the risk of osteoporosis and fractures, particularly in young adults, and low calcium intake and vitamin D deficiency may worsen these effects.

Supporting Evidence

  • Antiepileptic drugs have been linked to low bone density and osteoporosis.
  • Only 28% of adult neurologists reported screening for bone disease in patients on AEDs.
  • Low vitamin D levels are common in patients taking AEDs, contributing to bone health issues.

Takeaway

People who take certain medications for epilepsy might have weaker bones and be more likely to break them, especially if they don't get enough calcium and vitamin D.

Methodology

This review discusses the pathophysiologic mechanisms of bone disease associated with antiepileptic drug use and highlights strategies for prevention.

Potential Biases

There may be a general lack of awareness among physicians regarding the effects of AEDs on bone health.

Limitations

The review lacks long-term randomized controlled trials evaluating different therapeutic options for managing AED-induced bone loss.

Participant Demographics

The study includes both adult and pediatric populations, with a focus on neurologists' awareness of bone health effects.

Digital Object Identifier (DOI)

10.1186/1743-7075-3-36

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication